You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Asthma, anti-immunoglobulin E, omalizumab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

Active, not recruiting
  • Asthma
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Oct 23, 2022

Asthma, Infertility, Female Trial in Copenhagen (Omalizumab Injection, NaCl)

Recruiting
  • Asthma
  • Infertility, Female
  • Omalizumab Injection
  • NaCl
  • Copenhagen, Denmark
    Charlotte Suppli Ulrik
Dec 16, 2021

Urticaria Chronic Trial in Baltimore (Omalizumab)

Completed
Has Results
  • Urticaria Chronic
  • Baltimore, Maryland
    Johns Hopkins Asthma and Allergy Center
May 20, 2021

Kenota 1 CWS Method Comparison Validation Study

Recruiting
  • Allergy
  • Immunoglobulin E-Mediated Allergic Disorder
  • Total Immunoglobulin E, Obtained From Fingerstick Sample
  • Saint Paul, Minnesota
  • +2 more
Jan 27, 2023

Asthma, Allergic Rhinitis, Atopic Dermatitis Trial in Sacramento (Omalizumab, Placebo)

Completed
Has Results
  • Asthma
  • +2 more
  • Sacramento, California
    UC Davis Department of Dermatology
Jun 21, 2021

Increased Immunoglobulin E to Anti-herpes Simplex Virus -1

Recruiting
  • Atopic Dermatitis With a History of Eczema Herpeticum
  • +2 more
  • Xolair
  • Denver, Colorado
    National Jewish Health
Mar 4, 2021

Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

Not yet recruiting
  • Nasal Polyps
  • Shiraz, Fars, Iran, Islamic Republic of
    Imam Reza Allergy and Immunology clinic, Shiraz University of Me
May 31, 2022

Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab

Completed
  • Allergic Asthma
  • Uncontrolled Moderate to Severe
  • Omalizumab (CinnaGen)
  • Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
  • Ahvaz, Iran, Islamic Republic of
  • +21 more
Apr 3, 2023

Subjective Sleep Quality and Sleep Disorders in Severe Asthma

Active, not recruiting
  • Asthma
    • Tradate, Lombardia, Italy
      Istituti Clinici Maugeri Pneumologia
    Oct 17, 2022

    Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

    Not yet recruiting
    • Metastatic Colorectal Carcinoma
    • +3 more
    • Bevacizumab
    • +11 more
    • (no location specified)
    May 9, 2023

    Epithelial Barrier Integrity in Biologic Treatment Response of

    Not yet recruiting
    • Severe Eosinophilic Asthma w/wo CRSwNP
    • Mepolizumab 100 MG
    • Heraklion, Crete, Greece
      "PAGNI" University Hospital, Crete
    May 3, 2022

    Allergic Asthma Trial (omalizumab, )

    Completed
    Has Results
    • Allergic Asthma
    • (no location specified)
    Dec 9, 2022

    Nasal Polyps, Chronic Rhinosinusitis Trial in Worldwide (Omalizumab, Placebo)

    Completed
    Has Results
    • Nasal Polyps
    • Chronic Rhinosinusitis
    • Birmingham, Alabama
    • +78 more
    Mar 31, 2022

    Severe Allergic Asthma Trial in Taoyuan (Nocturnal Temperature Controlled Laminar Flow Device, None Device)

    Completed
    • Severe Allergic Asthma
    • Nocturnal Temperature Controlled Laminar Flow Device
    • None Device
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Jun 8, 2021

    Influenza A H1N1 Trial in London (SAB-176, Placebo)

    Active, not recruiting
    • Influenza A H1N1
    • SAB-176
    • Placebo
    • London, United Kingdom
      Queen Mary BioEnterprises Innovation Centre
    Oct 25, 2021

    Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

    Completed
    • Healthy Volunteers
    • CMAB007
    • Xolair
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Jun 8, 2023

    Asthma Trial in United States (Omalizumab, Placebo)

    Recruiting
    • Asthma
    • Phoenix, Arizona
    • +12 more
    Jan 13, 2022

    Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

    Active, not recruiting
    • Covid19
    • Omalizumab
    • Placebo
    • Niagara, Ontario, Canada
    • +2 more
    Nov 14, 2022

    Specific Immunotherapy With Pollinex Quattro on

    Completed
    • Rhinitis, Allergic
    • +4 more
    • Pollinex Quattro with tree- and grass pollen extracts and their mixtures
    • Cologne, Germany
      Outpatient Center Dr Stollewerk/Niebecker
    Feb 5, 2021

    Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps Trial in Baltimore (Omalizumab)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Nasal Polyps
    • Omalizumab
    • Baltimore, Maryland
    • +1 more
    Jan 18, 2023

    Food-specific IgG4-guided Elimination Diets Improve Allergy

    Completed
    • Rhinitis, Allergic
    • +4 more
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital，School of Medicine，Zhejiang Universit
      Sep 25, 2023

      Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

      Not yet recruiting
      • Grade 3b Follicular Lymphoma
      • +5 more
      • Biospecimen Collection
      • +9 more
      • (no location specified)
      Jun 6, 2023

      Asthma Trial in Paris (Attempt to withdrawal OMA treatment, Continuation of OMA treatment)

      Recruiting
      • Asthma
      • Attempt to withdrawal OMA treatment
      • Continuation of OMA treatment
      • Paris, Île De France, France
        Höpital Bichat-Claude Bernard
      Feb 9, 2022

      Anti-IL5 Biological Treatments on Blood IgE Levels in Severe

      Completed
      • Asthma
      • Asthma; Eosinophilic
      • Total IgE
      • +3 more
      • Ferrara, Italy
      • +7 more
      Nov 3, 2020

      Moderate-to-severe Allergic Asthma Trial in United States (Omalizumab)

      Terminated
      Has Results
      • Moderate-to-severe Allergic Asthma
      • Rolling Hills Estates, California
      • +11 more
      Feb 16, 2022